Centre Monticelli Paradis D Ophtalmologie

At Centre Monticelli Paradis D Ophtalmologie in Marseille, clinical research is focused on major ophthalmology conditions, especially age-related macular degeneration, diabetic macular edema, geographic atrophy, and other forms of retinal disease. The trials are designed to test new treatments, compare them with established care, and better understand long-term eye function and vision outcomes.

• Testing new therapies for neovascular age-related macular degeneration and related retinal neovascular diseases
• Evaluating treatments for diabetic macular edema and their impact on vision and retinal thickness
• Studying approaches to slow geographic atrophy and preserve sight in dry AMD
• Assessing safety, durability, and real-world usefulness of emerging ophthalmic treatments

The site’s research also includes work on uveitis, macular telangiectasia, and choroidal neovascularization, reflecting a broad effort to improve treatment effectiveness and long-term patient outcomes across retinal and inflammatory eye conditions.

This research area centers on progressive retinal damage, with a strong emphasis on geographic atrophy and dry age-related macular degeneration. Studies at the site are exploring whether new medicines can slow lesion growth, protect retinal tissue, and maintain visual function over time.

• Investigating therapies for geographic atrophy secondary to AMD
• Assessing whether new treatments can reduce the rate of retinal lesion expansion
• Monitoring long-term safety of promising complement-targeted and other retinal therapies
• Supporting better understanding of vision preservation in advanced macular disease

Several studies in this area aim to improve care for people living with slowly worsening central vision loss, with a focus on treatment effectiveness and sustained safety.

Another major focus is diabetic macular edema, where researchers are comparing eye treatments intended to reduce swelling, improve visual acuity, and lower the treatment burden for patients. The work includes both established therapies and newer options designed to offer longer-lasting control.

• Comparing treatments for diabetic macular edema to improve vision outcomes
• Evaluating options for patients with persistent or resistant retinal swelling
• Studying ways to reduce the frequency of eye injections while maintaining benefit
• Assessing the effectiveness of anti-VEGF and steroid-based approaches in retinal disease

These trials are aimed at finding practical, effective ways to manage chronic macular swelling and improve daily visual function for people with diabetes-related eye disease.

The site also contributes to research on newer ophthalmic therapies, including gene-based and sustained-delivery approaches for retinal disease. These studies are intended to test whether emerging treatments can offer durable control of neovascular AMD and related disorders while preserving vision.

• Testing advanced treatments for neovascular age-related macular degeneration
• Evaluating long-term safety and effectiveness of novel retinal therapies
• Studying approaches that may reduce ongoing treatment burden for patients
• Comparing newer interventions with standard anti-VEGF care

Overall, the research portfolio at this Marseille eye care center reflects a strong commitment to improving both immediate treatment response and long-term visual preservation in retinal disease.